Evidence map›Paper›PMID 37389308›Full record

ArticleEuropean physical journal plus2023

Testing of the siderophore deferoxamine amended in hydrogels for the cleaning of iron corrosion.

Luana Cuvillier, Arianna Passaretti, Elodie Guilminot, Edith Joseph

Abstract read
In one paragraph

Article in European physical journal plus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luana CuvillierLaboratory of Technologies for Heritage Materials, University of Neuchâtel, Bellevaux 51, 2000 Neuchâtel, Switzerland.ORCID 0000-0003-0364-5296
Arianna PassarettiLaboratory of Technologies for Heritage Materials, University of Neuchâtel, Bellevaux 51, 2000 Neuchâtel, Switzerland.ORCID 0000-0003-3039-4170
Elodie GuilminotArc'Antique Conservation and Research Laboratory, 26 Rue de la Haute Forêt, 44300 Nantes, France.ORCID 0000-0003-3437-4804
Edith JosephLaboratory of Technologies for Heritage Materials, University of Neuchâtel, Bellevaux 51, 2000 Neuchâtel, Switzerland.ORCID 0000-0001-6967-8141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioderived alternatives to commonly used complexing agents for the cleaning of iron artworks are sought for their natural origin and better biodegradability. Indeed, complexing agents currently used for the removal of undesired corrosion products from iron artworks can be difficult to control and their environmental impact is often overlooked. This paper studies the use of siderophores, focusing on the ability of one of them, deferoxamine, to be employed as an active agent loaded in polysaccharides hydrogels, on corrosion phases. Preliminary tests were conducted on artificially aged steel samples and further studies were performed on naturally corroded steel to assess the most performing application parameters. Long-term behavior of cleaned surface was assessed. Cleaning outcomes were compared with those obtainable with disodium ethylenediaminetetraacetic acid using optical microscopy, colorimetry and atomic absorption spectroscopy as well as Infrared and Raman micro-spectroscopies. Among the different gelling agents evaluated, agar applied when hot and gellan gum prepared at room temperature were the most effective gel formulations and agar left few residues over the treated surfaces. The protocol was then tested on altered steel artifacts belonging to heritage institutions in France. Encouraging outcomes in the removal of iron corrosion phases with green approaches are here presented. Graphical abstract:

Identifiers

PMID37389308
PMCPMC10299936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.